CT2 Program Lecture Series

All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:40 a.m. for those attending the lecture.

Principles of Cancer Drug Therapeutics Development

This is a series of weekly lectures delivered by CT² and UC San Diego faculty members focusing on the necessary sequential steps involved in drug development.

Topics in Cancer Drug Development

This is a series of lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

Upcoming Lectures

Date	Speaker	Affiliation	Title	Location
11/19/19	(Speaker Postponed)	UCSD	Angiogenesis	Comer Commons
11/26/19	Michael Bouvet, MD	UCSD	Development of Imaging Probes for Fluorescence Guided Surgery	Comer Commons
12/3/19	Jing Yang, PhD	UCSD	Epithelial-Mesenchymal Plasticity in Carcinoma Metastasis	Comer Commons
12/10/2019	Reuben Shaw, PhD	Salk	LKB1/STK11 mutant lung cancer: from pathways to drug targets	Comer Commons
12/17/19	William Gerwick, PhD	SIO	Ocean Life as a Source of Novel Anticancer Drugs: Updates and New Developments	Comer Commons
1/7/2020	Nicole Steinmetz, PhD	UCSD	NanoEngineering Gone Viral: Plant Virus-based Immunotherapies	Comer Commons
1/14/2020	Aaron Miller, MD	UCSD	Functional identification and therapeutic targeting of neoantigens in patients with solid tumors	Comer Commons
1/21/2020	Gerald Joyce, MD, PhD	Novartis	Drug Discovery across the Street at GNF	Comer Commons
1/28/2020	Christian Metallo, PhD	UCSD	Influence of Serine Availability on Tumor Lipid Metabolism	Comer Commons
2/4/2020	Gen-Sheng Feng, PhD	UCSD	Liver Cancer, from mechanism to early detection and new therapy	Comer Commons

Schedules for previous years